Претраживање
Приказ резултата 1-2 од 2
ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis
(Frontiers Media S.A., 2021)
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
(Frontiers in Immunology, 2021)